Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

55.02
Delayed Data
As of 4:00pm ET
 -1.34 / -2.38%
Today’s Change
35.41
Today|||52-Week Range
74.50
+28.82%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sharp Shalini
Chief Financial Officer & Executive Vice President
Sale3/18/201914,800$70.00$1.0M-17.55%
Kakkis Emil D
President & Chief Executive Officer
Buy9/11/20195,000$43.63$218.2K+25.22%
Kakkis Emil D
President & Chief Executive Officer
Sale3/05/20192,890$65.52$189.4K-14.45%
Kakkis Emil D
President & Chief Executive Officer
Sale3/01/20192,802$67.55$189.3K-16.57%
Sharp Shalini
Chief Financial Officer & Executive Vice President
Buy9/16/201924,880$6.86$170.7K+25.92%
Parschauer Karah
General Counsel & Executive Vice President
Sale6/21/20191,489$63.01$93.8K-9.97%
Kakkis Emil D
President & Chief Executive Officer
Sale5/21/20191,414$59.50$84.1K-5.28%
Sharp Shalini
Chief Financial Officer & Executive Vice President
Buy3/18/201912,000$6.86$82.3K-17.55%
Bedrosian Camille L
Chief Medical Officer & Executive Vice President
Sale1/30/20191,636$48.85$79.9K+15.37%
Parschauer Karah
General Counsel & Executive Vice President
Sale6/24/20191,226$61.50$75.4K-6.44%
Page of 8